123 related articles for article (PubMed ID: 16642479)
21. Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer.
Nugent Z; Demers AA; Wiseman MC; Mihalcioiu C; Kliewer EV
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2584-90. PubMed ID: 16284382
[TBL] [Abstract][Full Text] [Related]
22. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands.
Flohil SC; Koljenović S; de Haas ER; Overbeek LI; de Vries E; Nijsten T
Br J Dermatol; 2011 Oct; 165(4):874-81. PubMed ID: 21711333
[TBL] [Abstract][Full Text] [Related]
23. Basal cell carcinoma: histological classification and body-site distribution.
Raasch BA; Buettner PG; Garbe C
Br J Dermatol; 2006 Aug; 155(2):401-7. PubMed ID: 16882181
[TBL] [Abstract][Full Text] [Related]
24. Cancer risk after radiotherapy for breast cancer.
Levi F; Randimbison L; Te VC; La Vecchia C
Br J Cancer; 2006 Aug; 95(3):390-2. PubMed ID: 16804519
[TBL] [Abstract][Full Text] [Related]
25. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
[TBL] [Abstract][Full Text] [Related]
26. Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in The Netherlands.
van Hattem S; Aarts MJ; Louwman WJ; Neumann HA; Coebergh JW; Looman CW; Nijsten T; de Vries E
Br J Dermatol; 2009 Oct; 161(4):840-5. PubMed ID: 19438849
[TBL] [Abstract][Full Text] [Related]
27. Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012.
Asgari MM; Moffet HH; Ray GT; Quesenberry CP
JAMA Dermatol; 2015 Sep; 151(9):976-81. PubMed ID: 26039887
[TBL] [Abstract][Full Text] [Related]
28. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
29. Predicting the Risk of a Second Basal Cell Carcinoma.
Verkouteren JAC; Smedinga H; Steyerberg EW; Hofman A; Nijsten T
J Invest Dermatol; 2015 Nov; 135(11):2649-2656. PubMed ID: 26121210
[TBL] [Abstract][Full Text] [Related]
30. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
31. Incidence of second sarcomas: a cancer registry-based study.
Levi F; Randimbison L; Maspoli-Conconi M; Blanc-Moya R; La Vecchia C
Cancer Causes Control; 2014 Apr; 25(4):473-7. PubMed ID: 24463790
[TBL] [Abstract][Full Text] [Related]
32. Age-specific incidence of all neoplasms after colorectal cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Ann Epidemiol; 2014 Oct; 24(10):785-8. PubMed ID: 25169681
[TBL] [Abstract][Full Text] [Related]
33. Incidence of cancer in first-degree relatives of basal cell carcinoma patients.
van Rossum MM; Wopereis D; Hoyer T; Soerjomataram I; Schalkwijk J; van de Kerkhof PC; Kiemeney LA; Hoogerbrugge N
Arch Dermatol Res; 2009 Apr; 301(4):295-9. PubMed ID: 18985366
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of basal cell carcinoma in Lithuania, 1996-2010.
Jurciukonyte R; Vincerzevskiene I; Krilaviciute A; Bylaite M; Smailyte G
Br J Dermatol; 2013 Nov; 169(5):1100-5. PubMed ID: 23795568
[TBL] [Abstract][Full Text] [Related]
35. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
[TBL] [Abstract][Full Text] [Related]
36. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
[TBL] [Abstract][Full Text] [Related]
37. Second cancers following the diagnosis of Merkel cell carcinoma: a nationwide cohort study.
Koljonen V; Kukko H; Tukiainen E; Böhling T; Sankila R; Joensuu H; Pukkala E
Cancer Epidemiol; 2010 Feb; 34(1):62-5. PubMed ID: 20061203
[TBL] [Abstract][Full Text] [Related]
38. Earlier detection of patients' second primary basal cell carcinomas: a quantitative analysis.
Allen SB; Lortscher DN; Sengelmann RD
Dermatol Surg; 2007 Jan; 33(1):69-72. PubMed ID: 17214681
[TBL] [Abstract][Full Text] [Related]
39. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
40. Basal cell carcinoma on the trunk is associated with excessive sun exposure.
Neale RE; Davis M; Pandeya N; Whiteman DC; Green AC
J Am Acad Dermatol; 2007 Mar; 56(3):380-6. PubMed ID: 17097387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
